Pfizer Inc. (ETR:PFE)
20.75
-0.04 (-0.19%)
Jun 27, 2025, 5:35 PM CET
Pfizer Revenue
Pfizer had revenue of $13.72B USD in the quarter ending March 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to $62.46B, up 11.65% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.46B
Revenue Growth
+11.65%
P/S Ratio
2.04
Revenue / Employee
$771.16K
Employees
81,000
Market Cap
117.38B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Pfizer News
- 1 day ago - Pfizer hemophilia therapy succeeds in late-stage trial - Seeking Alpha
- 1 day ago - Pfizer's bleeding disorder therapy meets main goal in patients with certain antibodies - Reuters
- 1 day ago - Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI in Hemophilia A or B with Inhibitors - Wallstreet:Online
- 1 day ago - Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors - Business Wire
- 1 day ago - Heads up: Far-right lawmakers look to table no confidence vote against EU's von der Leyen - Forexlive
- 2 days ago - Ursula von der Leyen faces no-confidence vote over Pfizergate - Financial Times
- 2 days ago - Pfizer Could Be The Turnaround Story In The Pharmaceutical Space - Seeking Alpha
- 2 days ago - Pfizer declares $0.43 dividend - Seeking Alpha